Colorectal Cancer: Pathogenesis and Targeted Therapy
MedComm · 2025-03 · 6 (3)
DOI: 10.1002/mco2.70127 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 06.03.2025. Verfasst von Jingyuan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Digestive Diseases China-Canada Center of Research for Digestive Diseases Longhua Hospital Shanghai University of Traditional Chinese Me…. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 273 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Rising-Star Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Colorectal cancer (CRC) ranks among the most prevalent malignant neoplasms globally. A growing body of evidence underscores the pivotal roles of genetic alterations and dysregulated epigenetic modifications in the pathogenesis of CRC. In recent years, the reprogramming of tumor cell metabolism has been increasingly acknowledged as a hallmark of cancer. Substantial evidence suggests a crosstalk between tumor cell metabolic reprogramming and epigenetic modifications, highlighting a complex interplay between metabolism and the epigenetic genome that warrants further investigation. Biomarkers associated with the pathogenesis and metabolic characteristics of CRC hold significant clinical implications. Nevertheless, elucidating the genetic, epigenetic, and metabolic landscapes of CRC continues to pose considerable challenges. Here, we attempt to summarize the key genes driving the onset and progression of CRC and the related epigenetic regulators, clarify the roles of gene expression and signaling pathways in tumor metabolism regulation, and explore the potential crosstalk between epigenetic events and tumor metabolic reprogramming, providing a comprehensive mechanistic explanation for the malignant progression of CRC. Finally, by integrating reliable targets from genetics, epigenetics, and metabolic processes that hold promise for translation into clinical practice, we aim to offer more strategies to overcome the bottlenecks in CRC treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Digestive Diseases China-Canada Center of Research for Digestive Diseases Longhua Hospital Shanghai University of Traditional Chinese Medicine Shanghai China.
- State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine (Shanghai University of Traditional Chinese Medicine) Shanghai China.
- Department of Biochemistry Microbiology and Immunology Faculty of Medicine University of Ottawa Ottawa Ontario Canada.
- China-Canada Centre of Research for Digestive Diseases University of Ottawa Ottawa Ontario Canada.
ORCID-Profile: Yanqi Dang
Förderung
- Shanghai Rising-Star Program
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Pan, J., Wang, L., Ji, G., & Dang, Y. (2025). Colorectal Cancer: Pathogenesis and Targeted Therapy. MedComm, 6(3). https://doi.org/10.1002/mco2.70127
Vancouver
Li J, Pan J, Wang L, Ji G, Dang Y. Colorectal Cancer: Pathogenesis and Targeted Therapy. MedComm. 2025;6(3). doi:10.1002/mco2.70127
BibTeX
@article{Li2025,
author = {Li, Jingyuan and Pan, Jiashu and Wang, Lisheng and Ji, Guang and Dang, Yanqi},
title = {Colorectal Cancer: Pathogenesis and Targeted Therapy},
journal = {MedComm},
year = {2025},
volume = {6},
number = {3},
doi = {10.1002/mco2.70127}
}
EUVIMED